Acro Biomedical (ACBM) Cash from Operations Growth (5y) (2020 - 2025)
Acro Biomedical (ACBM) Cash from Operations Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.38% |
| Jun 30, 2025 | -5.52% |
| Mar 31, 2025 | 2.83% |
| Dec 31, 2024 | -18.14% |
| Sep 30, 2024 | 41.77% |
| Jun 30, 2024 | 45.97% |
| Mar 31, 2024 | 23.72% |
| Dec 31, 2023 | -15.69% |
| Sep 30, 2023 | 16.17% |
| Jun 30, 2023 | 14.92% |
| Mar 31, 2023 | -15.03% |
| Dec 31, 2022 | 20.49% |
| Sep 30, 2022 | 33.71% |
| Jun 30, 2022 | -81.50% |
| Mar 31, 2022 | 61.23% |
| Dec 31, 2021 | -235.66% |
| Sep 30, 2021 | -46.37% |
| Jun 30, 2021 | 139.78% |
| Mar 31, 2021 | -0.52% |
| Sep 30, 2020 | -111.74% |